We determined the prevalence of dyslipidemia in a Japanese cohort of renal allograft recipients and investigated clinical and genetic characteristics associated with having the disease. In total, 126 patients that received renal allograft transplants between February 2002 and August 2011 were studied, of which 44 recipients (34.9%) were diagnosed with dyslipidemia at 1 year after transplantatio...

OBJECTIVE Dyslipidemia is a preventable major risk factor for coronary heart disease (CHD). Despite an increased risk of CHD in type 1 diabetes, little is known concerning awareness and adequacy of dyslipidemia treatment in this population. In this report, we describe the prevalence of dyslipidemia and adequacy of pharmacological treatment in patients with type 1 diabetes and comparable nondiab...

A high percentage of type 2 diabetes mellitus (T2D) patients are also affected by dyslipidemia and chronic periodontitis (CP), but no studies have determined the gene expression in patients that are simultaneously affected by all three diseases. We investigated the systemic expression of immune-related genes in T2D, dyslipidemia, and CP patients. One hundred and fifty patients were separated in...

background: dyslipidemia is the major risk factor for cardiovascular disease in world and herbal medicines play an important role in the treatment of dyslipidemia. there are a few studies of sour tea ( hibiscus sabdariffa l.) effects on human. thus, the aim of the present study was to evaluate the efficacy of sour tea consumption on the lipid profile in dyslipidemic subjects. methods: a randomi...

background: dyslipidemia is considered as an important modifiable risk factor for cardiovascular disease (cvd). the link between childhood dyslipidemia and occurrence of  atherosclerosis and its sequels in adulthood are well-documented. this study aimed to systematically review the prevalence of dyslipidemia among iranian children and adolescents. materials and methods: an electronic search was...

objectives: cow urine ark (cua), known as “amrita” as mentioned in ayurveda, contains‎ anti-hyperglycemic and antioxidant effects. therefore, we designed the present study to evaluate the lipid ‎lowering activity of cua and its possible implication in metabolic syndrome.‎ materials and methods: thirty guinea pigs of either sex were divided into five groups: group 1 and 2 serving as a vehicle ‎a...

INTRODUCTION Psoriasis is a chronic skin ailment, which can be connected with other ailments including dyslipidemia. EXAMINEES AND METHODS Research included 70 patients affected by psoriasis. Both genders, above 18 years of age. Average age of the respondents was 47.14 (SD= ±15.41), which consisted of 36 men (51.43%) and 34 women (48.57%). The average duration of psoriasis was 15.52 (SD= ±12....

AIM to evaluate the association between the presence of dyslipidemia and the findings of coronary angiography in an Iranian population. METHODS this retrospective single center study was conducted on consecutive patients who underwent cardiac catheterization for cardiovascular symptoms in our center between March 2006 and 2007. The patients' medical records were studied in terms of clinical a...

Background: The chronic inflammatory state that occurs in obesity causes metabolic complications such as dyslipidemia, hypertension, insulin resistance, hepatosteatosis, and cardiovascular disorder. Dyslipidemia secondary to obesity, which is an important cause of morbidity, a worldwide concern. has essential role the pathogenesis disease (CVD). Objectives: aim this study was determine prevalen...

Background: Dyslipidemia constitutes a serious public health concern globally. It has been established that excessive fructose intake results in dyslipidemia; however, whether dexamethasone aggravates or alleviates fructose-induced dyslipidemia is unknown. Thus, we examined the effects of dexamethasone on dyslipidemia and hyperuricemia in high fructose-taking Wister rats. Methods: Twenty male...